Development of a radioimmunoassay for SR 31747A, a new sigma ligand, in human plasma

J Pharm Biomed Anal. 1996 May;14(7):783-91. doi: 10.1016/0731-7085(96)01751-7.

Abstract

A specific and sensitive radioimmunoassay was developed for SR 31747A, a new sigma ligand, using a monoclonal antibody. This antibody was produced from spleen lymphocytes of a mouse immunized with SR 31747A coupled to bovine serum albumin via a peptide bond using SR 120684A, a succinamic acid derivative of SR 31747A. Negligible binding occurred when metabolites, obtained by chemical synthesis or by "in-vitro" incubation with hepatic microsomal fraction, were tested for cross-reactivity. A quantitative recovery in serum of the exogenous analyte was obtained for all the concentrations tested and the quantification limit was found to be 0.25 ng ml-1 of SR 31747 (the non-salified derivative). Intra- and inter-assay relative standard deviations ranged from 6.3-10.9 and from 5.3% to 15.4% respectively. Furthermore, comparison of results from samples which were assayed by radioimmunoassay and gas chromatography demonstrated an excellent correlation (r = 0.984).

MeSH terms

  • Aniline Compounds / administration & dosage
  • Aniline Compounds / pharmacology
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / blood*
  • Antibodies, Monoclonal
  • Binding, Competitive
  • Chromatography, Gas
  • Cross Reactions
  • Cyclohexanes / blood*
  • Humans
  • Mice
  • Microsomes, Liver / drug effects
  • Microsomes, Liver / metabolism
  • Radioimmunoassay
  • Receptors, sigma / blood*
  • Reproducibility of Results
  • Spleen / cytology
  • Succinates / administration & dosage
  • Succinates / pharmacology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology

Substances

  • Aniline Compounds
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Cyclohexanes
  • Receptors, sigma
  • SR 120684A
  • Succinates
  • SR 31747